Researchers identified a major weakness in lung cancer by blocking FSP1, a protein that protects tumors from ferroptosis. In ...
Two recently published studies led by Brazilian scientists reveal the key roles of multifunctional proteins, STIP1 and Maspin ...
Summit Therapeutics' Ivonescimab targets non-small cell lung cancer through its dual anti-PD-1 plus anti-VEGF mechanism.